Buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet — RxCUI 351267
RxNorm drug concept · Semantic clinical drug
RxCUI 351267
Semantic clinical drug · SCD
● Current RxNorm concept 51 FDA products
106 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI351267
Official nameBuprenorphine 8 MG / naloxone 2 MG Sublingual Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbuprenorphine 8 MG (as buprenorphine HCl) / naloxone 2 MG (as naloxone HCl) Sublingual Tablet; buprenorphine HCl 8 MG / naloxone HCl 2 MG Sublingual Tablet
FDA products mapped51
Package NDCs mapped106
Reported Medicaid activity (SDUD)2,433,007 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Naloxone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Naloxone works by knocking opioids off their receptors in the brain — the spots opioids attach to in order to cause their effects. When those receptors are blocked by naloxone, bre...
- What exactly does naloxone injection do in an overdose?
- Call 911 immediately — that's not optional. Naloxone wears off faster than most opioids, so even if the person wakes up and seems okay, they can slip back into overdose once the na...
- What do I do after I give someone a dose of naloxone injection?
🕸️ Concept Web — How Buprenorphine 8 MG / naloxone 2 MG Sublingual Ta... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet
RxCUI 351267 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Buprenorphine
1819IN -
Naloxone
7242IN -
Buprenorphine / naloxone
352364MIN
-
Buprenorphine
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Buprenorphine / naloxone Sublingual Tablet
378762SCDF -
Buprenorphine / naloxone Oral Product
1151359SCDG -
Buprenorphine / naloxone Pill
1151360SCDG -
Buprenorphine / naloxone Sublingual Product
1294831SCDG -
Sublingual Tablet
317007DF -
Oral Product
1151131DFG -
Pill
1151133DFG -
Sublingual Product
1294706DFG
-
Buprenorphine / naloxone Sublingual Tablet
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Buprenorphine 8 MG
353391SCDC -
Naloxone 2 MG
353392SCDC
-
Buprenorphine 8 MG
Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Buprenorphine 8 MG
SCDC · 353391 -
Naloxone 2 MG
SCDC · 353392 -
Buprenorphine / naloxone Sublingual Tablet
SCDF · 378762 -
Buprenorphine / naloxone Oral Product
SCDG · 1151359 -
Buprenorphine / naloxone Pill
SCDG · 1151360 -
Buprenorphine / naloxone Sublingual Product
SCDG · 1294831
📦 FDA Products & Package NDCs
51 products · 106 package NDCs
106 package NDCs map to RxCUI 351267 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 67296-2191-01 | 12 TABLET in 1 BOTTLE, PLASTIC (67296-2191-1) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Redpharm Drug | 2020-09-01 |
| 67296-2191-06 | 6 TABLET in 1 BOTTLE, PLASTIC (67296-2191-6) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Redpharm Drug | 2020-09-01 |
| 67877-0606-30 | 30 TABLET in 1 BOTTLE (67877-606-30) | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2026-07-03 |
| 67877-0606-84 | 3 BLISTER PACK in 1 CARTON (67877-606-84) / 10 TABLET in 1... | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2026-07-03 |
| 67877-0606-90 | 90 TABLET in 1 BOTTLE (67877-606-90) | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2026-07-03 |
| 67877-0607-30 | 30 TABLET in 1 BOTTLE (67877-607-30) | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2026-07-03 |
| 67877-0607-84 | 3 BLISTER PACK in 1 CARTON (67877-607-84) / 10 TABLET in 1... | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2026-07-03 |
| 67877-0607-90 | 90 TABLET in 1 BOTTLE (67877-607-90) | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2026-07-03 |
| 70518-3389-00 | 30 TABLET in 1 BLISTER PACK (70518-3389-0) | Buprenorphine and Naloxone | REMEDYREPACK INC. | 2022-03-16 |
| 70518-3844-00 | 30 TABLET in 1 BLISTER PACK (70518-3844-0) | buprenorphine hydrochloride and naloxone hydrochloride dihydrate | REMEDYREPACK INC. | 2023-08-29 |
| 71335-1378-00 | 42 TABLET in 1 BOTTLE (71335-1378-0) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-01 | 30 TABLET in 1 BOTTLE (71335-1378-1) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2019-10-25 |
| 71335-1378-02 | 60 TABLET in 1 BOTTLE (71335-1378-2) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-03 | 90 TABLET in 1 BOTTLE (71335-1378-3) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-04 | 120 TABLET in 1 BOTTLE (71335-1378-4) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-05 | 14 TABLET in 1 BOTTLE (71335-1378-5) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-06 | 28 TABLET in 1 BOTTLE (71335-1378-6) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-07 | 6 TABLET in 1 BOTTLE (71335-1378-7) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-08 | 10 TABLET in 1 BOTTLE (71335-1378-8) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1378-09 | 21 TABLET in 1 BOTTLE (71335-1378-9) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2024-05-20 |
| 71335-1725-00 | 42 TABLET in 1 BOTTLE (71335-1725-0) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-01 | 30 TABLET in 1 BOTTLE (71335-1725-1) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-02 | 60 TABLET in 1 BOTTLE (71335-1725-2) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-03 | 90 TABLET in 1 BOTTLE (71335-1725-3) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-04 | 120 TABLET in 1 BOTTLE (71335-1725-4) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-05 | 14 TABLET in 1 BOTTLE, PLASTIC (71335-1725-5) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-06 | 28 TABLET in 1 BOTTLE, PLASTIC (71335-1725-6) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1725-07 | 6 TABLET in 1 BOTTLE, PLASTIC (71335-1725-7) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2020-10-23 |
| 71335-1725-08 | 10 TABLET in 1 BOTTLE, PLASTIC (71335-1725-8) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2022-05-25 |
| 71335-1725-09 | 21 TABLET in 1 BOTTLE, PLASTIC (71335-1725-9) | Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | Bryant Ranch Prepack | 2024-04-04 |
| 71335-1858-00 | 42 TABLET in 1 BOTTLE, PLASTIC (71335-1858-0) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-01 | 30 TABLET in 1 BOTTLE, PLASTIC (71335-1858-1) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2021-05-07 |
| 71335-1858-02 | 60 TABLET in 1 BOTTLE, PLASTIC (71335-1858-2) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2021-06-08 |
| 71335-1858-03 | 90 TABLET in 1 BOTTLE, PLASTIC (71335-1858-3) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-04 | 120 TABLET in 1 BOTTLE, PLASTIC (71335-1858-4) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-05 | 14 TABLET in 1 BOTTLE, PLASTIC (71335-1858-5) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-06 | 28 TABLET in 1 BOTTLE, PLASTIC (71335-1858-6) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-07 | 6 TABLET in 1 BOTTLE, PLASTIC (71335-1858-7) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-08 | 10 TABLET in 1 BOTTLE, PLASTIC (71335-1858-8) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-1858-09 | 21 TABLET in 1 BOTTLE, PLASTIC (71335-1858-9) | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | 2022-02-14 |
| 71335-2828-01 | 30 TABLET in 1 BOTTLE (71335-2828-1) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2025-10-23 |
| 71335-2981-00 | 42 TABLET in 1 BOTTLE, PLASTIC (71335-2981-0) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-01 | 30 TABLET in 1 BOTTLE, PLASTIC (71335-2981-1) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-02 | 60 TABLET in 1 BOTTLE, PLASTIC (71335-2981-2) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-03 | 90 TABLET in 1 BOTTLE, PLASTIC (71335-2981-3) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-04 | 120 TABLET in 1 BOTTLE, PLASTIC (71335-2981-4) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-05 | 14 TABLET in 1 BOTTLE, PLASTIC (71335-2981-5) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-06 | 28 TABLET in 1 BOTTLE, PLASTIC (71335-2981-6) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2026-04-16 |
| 71335-2981-07 | 6 TABLET in 1 BOTTLE, PLASTIC (71335-2981-7) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2025-12-08 |
| 71335-2981-08 | 10 TABLET in 1 BOTTLE, PLASTIC (71335-2981-8) | Buprenorphine and Naloxone | Bryant Ranch Prepack | 2025-10-27 |
Observed labelers:
Bryant Ranch Prepack (54) ·
Ascend Laboratories, LLC (6) ·
Amneal Pharmaceuticals LLC (4) ·
Clinical Solutions Wholesale, LLC (4) ·
Redpharm Drug (4) ·
Sun Pharmaceutical Industries, Inc. (4)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.